StreetAccount Sector Summary - Healthcare Weekly Recap
J&J talc settlement and Paramount/WBD deal delayed amid legal challenges among recent litigation themes (31-Jul)
Street Takeaways - GLP-1 Rx Tracker for week ended July 24th; Foundayo TRx ~+9.8% w/w; Oral Wegovy TRx +1.2% w/w
StreetAccount Summary: Notable Drug Events expected for the week of 2-Aug
StreetAccount Summary - US Pre-market trading update
StreetAccount Sector Summary - Healthcare Pre-Market
StreetAccount Summary - US Pre-market trading
Novo Nordisk announces headline results from the ZEUS cardiovascular outcomes phase 3 trial; did not translate into MACE risk reduction vs placebo (DKK 309.85, -21.05)
StreetAccount Sector Summary - Healthcare Post-Market
ESG Daily - Cyclosporiasis impacting US consumer choices; US states reach deal on nuclear waste
Powered by FactSet Research Systems Inc.